Stage II Esophageal Cancer Completed Phase 1 Trials for Fluorouracil (DB00544)

IndicationStatusPhase
DBCOND0029703 (Stage II Esophageal Cancer)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01561014Oxaliplatin, Fluorouracil, Erlotinib Hydrochloride, and Radiation Therapy Before Surgery and Erlotinib Hydrochloride After Surgery in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal JunctionTreatment